Newsletter May 2021 No.203
Top News
"Press Conference by the Chairman of the JPMA" Held
On March 23, 2021, the “JPMA Chairman’s Press Conference” was held at the Nihonbashi Life Science Hub (Chuo Ward, Tokyo).Jōji Nakayama, Chairman of the JPMA, provided an explanation of the “JPMA Policy Proposals 2021” and other topics. The press conference was attended by 42 members of the press (22 in person and 20 watching the webcast), and a lively question-and-answer session took place on the day of the event.
Topics
- The 32nd JPMA Policy Seminar" Held Contribution of Innovation for Patients: Drug Discovery in the With COVID-19 Era
- JPMA Media Forum" was held on the theme "What is a Vaccine? -In the wake of the Corona Disaster, learn about vaccines once again" - "2021 Life Science IP Policy Seminar
- The 2021 Life Science IP Forum was held, with the theme "How to Handle IP Rights in Response to Pandemics, Including COVID-19
- JPMA Media Forum" was held under the theme "Reconsidering the Various Values of Pharmaceuticals: What Contributions to Society are Expected from Pharmaceuticals?
- Workshop for Persons Responsible for Product Information Overview and Management and for Practical Responsibility in FY2020" was held.
- Held the "FY2020 Meeting of Compliance Managers and Managers in Charge of Compliance Management
Policy Research Institute
From JPMA
From the “Press Conference by the President of the JPMA”